Keep Us Strong WikiLeaks logo

Currently released so far... 97115 / 251,287

Articles

Browse latest releases

Browse by creation date

Browse by origin

A B C D F G H I J K L M N O P Q R S T U V W Y Z

Browse by tag

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
ETRD EAGR ETTC EAID ECON EFIN ECIN EINV ELAB EAIR ENRG EPET EWWT ECPS EIND EMIN ELTN EC ETMIN EUC EZ ET ELECTIONS ENVR EU EUN EG EINT ER ECONOMICS ES EMS ENIV EEB EN ECE ECOSOC EK ENVIRONMENT EFIS EI EWT ENGRD ECPSN EXIM EIAD ERIN ECPC EDEV ENGY ECTRD EPA ESTH ECCT EINVECON ENGR ERTD EUR EAP EWWC ELTD EL EXIMOPIC EXTERNAL ETRDEC ESCAP ECO EGAD ELNT ECONOMIC ENV ETRN EIAR EUMEM ENRGPARMOTRASENVKGHGPGOVECONTSPLEAID EREL ECOM ECONETRDEAGRJA ETCC ETRG ECONOMY EMED ETR ENERG EITC EFINOECD EURM EENG ERA EXPORT ENRD ECONEINVETRDEFINELABETRDKTDBPGOVOPIC EGEN EBRD EVIN ETRAD ECOWAS EFTA ECONETRDBESPAR EGOVSY EPIN EID ECONENRG EDRC ESENV ETT EB ENER ELTNSNAR ECHEVARRIA ETRC EPIT EDUC ESA EFI ENRGY ESCI EE EAIDXMXAXBXFFR EETC ECIP EIAID EIVN EBEXP ESTN EING EGOV ETRA EPETEIND ELAN ETRDGK EAIDRW ETRDEINVECINPGOVCS EPEC ENVI ELN EAG EPCS EPRT EPTED ETRB EUM EAIDS EFIC EFINECONEAIDUNGAGM EAIDAR ESF EIDN ELAM EDU EV EAIDAF ECN EDA EXBS EINTECPS ENRGTRGYETRDBEXPBTIOSZ EPREL EAC EINVEFIN ETA EAGER EINDIR ECA ECLAC ELAP EITI EUCOM ECONEFINETRDPGOVEAGRPTERKTFNKCRMEAID EARG ELDIN EINVKSCA ENNP EFINECONCS EFINTS ECCP ETC EAIRASECCASCID EINN ETRP EAIDNI EFQ ECOQKPKO EGPHUM EBUD ECONEINVEFINPGOVIZ ENERGY ELB EINDETRD EMI ECONEFIN EIB EURN ETRDEINVTINTCS EIN EFIM ETIO ELAINE EMN EATO EWTR EIPR EINVETC ETTD ETDR EIQ ECONCS EPPD ENRGIZ EISL ESPINOSA ELEC EAIG ESLCO EUREM ENTG ERD EINVECONSENVCSJA EEPET EUNCH ECINECONCS ETRO ETRDECONWTOCS ECUN EFND EPECO EAIRECONRP ERGR ETRDPGOV ECPN ENRGMO EPWR EET EAIS EAGRE EDUARDO EAGRRP EAIDPHUMPRELUG EICN ECONQH EVN EGHG ELBR EINF EAIDHO EENV ETEX ERNG ED
KMDR KPAO KPKO KJUS KCRM KGHG KFRD KWMN KDEM KTFN KHIV KGIC KIDE KSCA KNNP KHUM KIPR KSUM KISL KIRF KCOR KRCM KPAL KWBG KN KS KOMC KSEP KFLU KPWR KTIA KSEO KMPI KHLS KICC KSTH KMCA KVPR KPRM KE KU KZ KFLO KSAF KTIP KTEX KBCT KOCI KOLY KOR KAWC KACT KUNR KTDB KSTC KLIG KSKN KNN KCFE KCIP KGHA KHDP KPOW KUNC KDRL KV KPREL KCRS KPOL KRVC KRIM KGIT KWIR KT KIRC KOMO KRFD KUWAIT KG KFIN KSCI KTFIN KFTN KGOV KPRV KSAC KGIV KCRIM KPIR KSOC KBIO KW KGLB KMWN KPO KFSC KSEAO KSTCPL KSI KPRP KREC KFPC KUNH KCSA KMRS KNDP KR KICCPUR KPPAO KCSY KTBT KCIS KNEP KFRDCVISCMGTCASCKOCIASECPHUMSMIGEG KNNB KGCC KINR KPOP KMFO KENV KNAR KVIR KDRG KDMR KFCE KNAO KDEN KGCN KICA KIMMITT KMCC KLFU KMSG KSEC KUM KCUL KMNP KSMT KCOM KOMCSG KSPR KPMI KRAD KIND KCRP KAUST KWAWC KTER KCHG KRDP KPAS KITA KTSC KPAOPREL KWGB KIRP KJUST KMIG KLAB KTFR KSEI KSTT KAPO KSTS KLSO KWNN KPOA KHSA KNPP KPAONZ KBTS KWWW KY KJRE KPAOKMDRKE KCRCM KSCS KWMNCI KESO KWUN KPLS KIIP KEDEM KPAOY KRIF KGICKS KREF KTRD KFRDSOCIRO KTAO KJU KWMNPHUMPRELKPAOZW KEN KO KNEI KEMR KKIV KEAI KWAC KRCIM KWCI KFIU KWIC KCORR KOMS KNNO KPAI KBWG KTTB KTBD KTIALG KILS KFEM KTDM KESS KNUC KPA KOMCCO KCEM KRCS KWBGSY KNPPIS KNNPMNUC KWN KERG KLTN KALM KCCP KSUMPHUM KREL KGH KLIP KTLA KAWK KWMM KVRP KVRC KAID KSLG KDEMK KX KIF KNPR KCFC KFTFN KTFM KPDD KCERS KMOC KDEMAF KMEPI KEMS KDRM KEPREL KBTR KEDU KNP KIRL KNNR KMPT KISLPINR KTPN KA KJUSTH KPIN KDEV KTDD KAKA KFRP KWNM KTSD KINL KJUSKUNR KWWMN KECF KWBC KPRO KVBL KOM KFRDKIRFCVISCMGTKOCIASECPHUMSMIGEG KEDM KFLD KLPM KRGY KNNF KICR KIFR KM KWMNCS KAWS KLAP KPAK KDDG KCGC KID KNSD KMPF KPFO KDP KCMR KRMS KNPT KNNNP KTIAPARM KDTB KNUP KPGOV KNAP KNNC KUK KSRE KREISLER KIVP KQ KTIAEUN KPALAOIS KRM KISLAO KWM KFLOA
PHUM PINR PTER PGOV PREL PREF PL PM PHSA PE PARM PINS PK PUNE PO PALESTINIAN PU PBTS PROP PTBS POL POLI PA PGOVZI POLMIL POLITICAL PARTIES POLM PD POLITICS POLICY PAS PMIL PINT PNAT PV PKO PPOL PERSONS PING PBIO PH PETR PARMS PRES PCON PETERS PRELBR PT PLAB PP PAK PDEM PKPA PSOCI PF PLO PTERM PJUS PSOE PELOSI PROPERTY PGOVPREL PARP PRL PNIR PHUMKPAL PG PREZ PGIC PBOV PAO PKK PROV PHSAK PHUMPREL PROTECTION PGOVBL PSI PRELPK PGOVENRG PUM PRELKPKO PATTY PSOC PRIVATIZATION PRELSP PGOVEAIDUKNOSWGMHUCANLLHFRSPITNZ PMIG PREC PAIGH PROG PSHA PARK PETER POG PHUS PPREL PS PTERPREL PRELPGOV POV PKPO PGOVECON POUS PGOVPRELPHUMPREFSMIGELABEAIDKCRMKWMN PWBG PMAR PREM PAR PNR PRELPGOVEAIDECONEINVBEXPSCULOIIPBTIO PARMIR PGOVGM PHUH PARTM PN PRE PTE PY POLUN PPEL PDOV PGOVSOCI PIRF PGOVPM PBST PRELEVU PGOR PBTSRU PRM PRELKPAOIZ PGVO PERL PGOC PAGR PMIN PHUMR PVIP PPD PGV PRAM PINL PKPAL PTERE PGOF PINO PHAS PODC PRHUM PHUMA PREO PPA PEPFAR PGO PRGOV PAC PRESL PORG PKFK PEPR PRELP PREFA PNG PGOVPHUMKPAO PRELECON PINOCHET PFOR PGOVLO PHUMBA PRELC PREK PHUME PHJM POLINT PGOVPZ PGOVKCRM PGOVE PHALANAGE PARTY PECON PEACE PROCESS PLN PRELSW PAHO PEDRO PRELA PASS PPAO PGPV PNUM PCUL PGGV PSA PGOVSMIGKCRMKWMNPHUMCVISKFRDCA PGIV PRFE POGOV PEL PBT PAMQ PINF PSEPC POSTS PHUMPGOV PVOV PHSAPREL PROLIFERATION PENA PRELTBIOBA PIN PRELL PGOVPTER PHAM PHYTRP PTEL PTERPGOV PHARM PROTESTS PRELAF PKBL PRELKPAO PKNP PARMP PHUML PFOV PERM PUOS PRELGOV PHUMPTER PARAGRAPH PERURENA PBTSEWWT PCI PETROL PINSO PINSCE PQL PEREZ PBS

Browse by classification

Community resources

courage is contagious

Viewing cable 05LIMA3794, ELI LILLY STRUGGLING WITH PATENT PIRACY

If you are new to these pages, please read an introduction on the structure of a cable as well as how to discuss them with others. See also the FAQs

Understanding cables
Every cable message consists of three parts:
  • The top box shows each cables unique reference number, when and by whom it originally was sent, and what its initial classification was.
  • The middle box contains the header information that is associated with the cable. It includes information about the receiver(s) as well as a general subject.
  • The bottom box presents the body of the cable. The opening can contain a more specific subject, references to other cables (browse by origin to find them) or additional comment. This is followed by the main contents of the cable: a summary, a collection of specific topics and a comment section.
To understand the justification used for the classification of each cable, please use this WikiSource article as reference.

Discussing cables
If you find meaningful or important information in a cable, please link directly to its unique reference number. Linking to a specific paragraph in the body of a cable is also possible by copying the appropriate link (to be found at theparagraph symbol). Please mark messages for social networking services like Twitter with the hash tags #cablegate and a hash containing the reference ID e.g. #05LIMA3794.
Reference ID Created Released Classification Origin
05LIMA3794 2005-09-01 21:40 2011-08-25 00:00 UNCLASSIFIED//FOR OFFICIAL USE ONLY Embassy Lima
This record is a partial extract of the original cable. The full text of the original cable is not available.
UNCLAS SECTION 01 OF 02 LIMA 003794 
 
SIPDIS 
 
SENSITIVE 
 
DEPT FOR WHA/AND, EB/IPE SWILSON 
COMMERCE FOR 4331/MAC/WH/MCAMERON 
DOC FOR J. BOGER 
USTR FOR B. WILSON, B. HARMAN 
 
E.O. 12958: N/A 
TAGS: ECON ETRD KIPR PE
SUBJECT: ELI LILLY STRUGGLING WITH PATENT PIRACY 
 
 
1.  (SBU) Summary.  Eli Lilly, one of the ten pharmaceutical 
companies that hold patents in Peru, continues to combat the 
piracy of one of its best selling products, Zyprexa. 
According to Eli Lilly representatives, two local 
distributors, Ozone and PharmaIndustria, are selling copies 
of Zyprexa on the local market.  One pirated version, sold 
by Ozone, is a slight modification of Lilly's molecule; the 
other version is structurally identical.  Indecopi, Peru's 
IPR administrator, has yet to take action on these cases, 
claiming that Eli Lilly must prove that Ozone and Farma 
Industria are selling pirated copies of Zyprexa.  Eli Lilly 
has lost over $2.4 million in sales.  We are investigating 
whether Indecopi's actions violate Article 28 of the TRIPS 
agreement, which states the rights of patent holders, and 
Article 34, which places the burden of proof on the alleged 
infringer.  End Summary. 
 
Two Copies of Zyprexa Available 
------------------------------- 
 
2.  (SBU) We met with Edgard Olaizola, General Manager of 
Eli Lilly Peru, on August 31 to discuss violations of 
intellectual property rights in the pharmaceutical arena. 
Olaizola informed us that Eli Lilly, which holds five 
pharmaceutical patents in Peru, is facing two patent 
violations.  Both violations involve Eli Lilly's Zyprexa 
drug (olanzapine), which is Lilly's top selling product for 
schizophrenia and bipolar disorder.  Lilly sells olanzapine 
worldwide and holds a patent for this product in countries 
where the product is sold.  Eli Lilly also holds exclusivity 
rights for the formulation and several processes of 
olanzapine.  Eli Lilly sells Zyprexa primarily to Peruvian 
government health institutions, including EsSalud and police 
and military hospitals. 
 
3.  (SBU) In January 2005, local distributor Ozone began 
selling a copy of Zyprexa, manufactured by Microlab in 
India.  According to Eli Lilly lab analysis, the Ozone drug 
is a slight modification of olanzapine.  In February, 
Indecopi, at Eli Lilly's request, issued a precautionary 
measure against Ozone based on the possible infringement of 
Lilly's process patent.  The precautionary measure 
prohibited Ozone from selling the product.  Indecopi, 
however, lifted the precautionary measure on May 31, several 
weeks before the GOP launched its annual procurement bid for 
medications. 
 
4.  (SBU) In June 2005, Farma Industria, one of Peru's 
largest pharmaceutical companies and producers of generic 
drugs, introduced another copy of Zyprexa to the market. 
Cipla, also based in India, manufactures this copy of 
Zyprexa.  Although Farma Industria claims that it sells a 
different form of olanzapine, Eli Lilly studies show that 
the drug is in fact an exact copy of Lilly's patented 
olanzapine. 
 
Indecopi Fails to Act 
--------------------- 
 
5.  (SBU) Eli Lilly officials met several times with 
Indecopi officials, who have yet to take any action.  Nestor 
Escovero, Director of Indecopi's patent office, informed Eli 
Lilly that the company needed to prove that the new drugs 
were pirated copies.  According to Olaizola, Indecopi's 
patent office staff work closely with Peruvian 
pharmaceutical distributors, advising them on generic drug 
production.  One patent examiner, claims Olaizola, is now 
the head of Ozone's regulatory department.  Olaizola asserts 
that Indecopi tends to favor local distributors over foreign 
companies and doubts that it will do anything to stop the 
sale of pirated drugs.  (Note and Comment: Indecopi is also 
targeting other multinationals.  In a recent unannounced 
visit to the Swissotel, now an American company, Indecopi 
officials demanded to see all software licenses.  Officials 
were disappointed when the hotel produced the necessary 
documents.  This is an example of Indecopi's lack of 
understanding and deliberate targeting of foreign companies. 
It also underscores the cost of doing business in Peru.  End 
Note and Comment.) 
 
6.  (SBU)  Eli Lilly, as a result of Indecopi's inaction and 
the lifting of the precautionary measure in June, has lost 
market share and estimates damages at $2.4 million in lost 
sales.  The GOP held eight procurement bids totaling 
$300,000 each for pharmaceutical supplies to EsSalud and 
military/police hospitals in June-August; Eli Lilly won none 
of these bids, despite holding previous contracts with the 
GOP.  Instead, Ozone and Farma Industria earned GOP 
contracts.  Eli Lilly appealed the procurement process. 
 
Possible Violation of TRIPS? 
---------------------------- 
 
7.  (SBU)  Despite Eli Lilly's claims that both Ozone and 
Farma Industria are selling pirated copies of Zyprexa, 
Indecopi has placed the burden of proof on Eli Lilly instead 
of the Peruvian companies.  Article 28 of the WTO TRIPS 
Agreement grants certain rights to patent holders.  Article 
34 clearly states that in cases of copyright infringement, 
the burden of proof should be placed on the alleged 
infringer, not the patent holder.  Indecopi's failure to 
fully investigate Eli Lilly's claims may be a direct 
violation of Peru's obligations under the TRIPS agreement. 
 
Comment 
------- 
 
8.  (SBU)  Eli Lilly is not the first pharmaceutical company 
to face patent problems in Peru.  Although the GOP is a 
member of the WTO, signatory to the TRIPS agreement and is 
in the process of negotiating a Free Trade Agreement with 
the United States, government officials do not always act in 
accordance with international regulations.  We will arrange 
a conference call with Eli Lilly and the Department of 
Commerce to discuss the facts of this case and the possible 
TRIPS violations.  We will also bring this case to the 
attention of the Peruvian FTA negotiators, stressing the 
importance of upholding intellectual property rights, 
particularly during negotiations. 
 
STRUBLE